id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-D-1197-0005,FDA,FDA-2012-D-1197,"The Honorable Pete Olson et al to the Commissioner, FDA - Letter",Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2013-02-28T21:04:16Z,,0,0,090000648119b8ac
FDA-2012-D-1197-0004,FDA,FDA-2012-D-1197,FDA Office of Legislation Response to the Honorable Pete Olson,Other,Letter(s),2012-12-20T05:00:00Z,2012,12,2012-12-20T05:00:00Z,,2012-12-20T15:54:26Z,,0,0,0900006481193e6f
FDA-2012-D-1197-0003,FDA,FDA-2012-D-1197,FDA Office of Legislation Response to the Honorable Gene Green - Letter,Other,Letter(s),2012-12-20T05:00:00Z,2012,12,2012-12-20T05:00:00Z,,2012-12-20T15:52:24Z,,0,0,0900006481193e6d
FDA-2012-D-1197-0001,FDA,FDA-2012-D-1197,Draft Guidance for Industry on Certification of Designated Medical Gases; Availability,Notice,Notice of Availability,2012-12-18T05:00:00Z,2012,12,2012-12-18T05:00:00Z,2013-02-20T04:59:59Z,2013-02-09T03:01:18Z,2012-30382,0,0,0900006481190823
FDA-2012-D-1197-0002,FDA,FDA-2012-D-1197,Draft Guidance for Industry on Certification of Designated Medical Gases,Other,Guidance,2012-12-18T05:00:00Z,2012,12,2012-12-18T05:00:00Z,2013-02-20T04:59:59Z,2024-11-12T05:11:30Z,,1,0,0900006481190c06